Treatment of central retinal vein occlusion-related macular edema with intravitreal bevacizumab (Avastin®): Preliminary results

Klinische Monatsblatter fur Augenheilkunde

Volumn 225, Issue 5, 2008, Pages 397-400

  Pournaras, J A C ^a   Nguyen, C ^a   Vaudaux, J D ^a   Konstantinidis, L ^a   Ambresin, A ^a   Wolfensberger, Thomas ^a,b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b JULES GONIN EYE HOSPITAL   (Switzerland)

Author keywords

Bevacizumab; CRVO; Macular edema

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPEREMIA; INJECTION SITE REACTION; MALE; OPTICAL COHERENCE TOMOGRAPHY; RETINA FOVEA; RETINA MACULA EDEMA; RETREATMENT; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; TREATMENT OUTCOME;

EID: 47649093567     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1027258     Document Type: Article

References (9)

1. Aiello LP, Avery RL, Arrigg PG et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480-1487
2. Boyd SR, Zachary I, Chakravarthy U et al. Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. Arch Ophthalmol 2002; 120: 1644-1650
3. Antonetti DA, Barber AJ, Hollinger LA et al. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem 1999; 274: 23463-23467
4. Goff MJ, Jumper JM, Yang SS et al. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion. Retina 2006; 26: 896-901
5. Iturralde D, Spaide RF, Meyerle CB et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 2006; 26: 279-284
6. Pe'er J, Folberg R, Itin A et al. Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology 1998; 105: 412-416
7. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995; 108 (Pt 6): 2369-2379
8. Roberts WG, Palade GE. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res 1997; 57: 765-772
9. Stahl A, Agostini H, Hansen LL et al. Bevacizumab in retinal vein occlusion-results of a prospective case series. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1429-1436